Dry Eye Disease Statistics & Facts 2026
Dry eye disease (DED) is one of the most common reasons for eye care visits worldwide, affecting hundreds of millions of people. The rise of digital device use has significantly increased prevalence, particularly among younger populations. This page compiles current statistics from the TFOS DEWS II report, National Eye Institute, and peer-reviewed studies.
Key Takeaways
- 1.Dry eye disease affects approximately 344 million people worldwide and over 16 million diagnosed Americans.
- 2.Women are twice as likely as men to develop dry eye, with prevalence increasing significantly after age 50.
- 3.Screen use reduces blink rate by up to 66%, making digital device users significantly more susceptible.
- 4.MGD (Meibomian Gland Dysfunction) is involved in up to 86% of dry eye cases — treating the glands is crucial.
- 5.The lifetime cost of managing moderate-severe dry eye can reach $55,000-$83,000 per patient.
- 6.Modern treatments like LipiFlow and IPL show 80-87% improvement rates when targeting the root cause.
Global Prevalence
Dry eye disease affects a significant portion of the global adult population.
An estimated 344 million people globally suffer from dry eye disease, making it one of the most prevalent ocular conditions.
Reported prevalence varies from 5% to 50% depending on diagnostic criteria, population studied, and geographic region.
Women are approximately twice as likely as men to develop dry eye disease, partly due to hormonal factors.
Dry Eye in the United States
Millions of Americans experience dry eye symptoms regularly.
Approximately 16.4 million adults in the United States have been diagnosed with dry eye disease.
An estimated 6 million additional Americans experience dry eye symptoms but have not been diagnosed.
Direct medical costs of dry eye disease in the US are estimated at $3.84 billion annually, with indirect costs pushing the total much higher.
Digital Eye Strain & Screens
Screen time has become a major driver of dry eye symptoms.
Approximately 65% of Americans report experiencing digital eye strain symptoms, including dryness, irritation, and blurred vision.
Blink rate drops by up to 66% during concentrated screen use, from ~15 blinks/min to ~5 blinks/min, causing tear film instability.
American adults spend an average of 7+ hours per day looking at digital screens, up from 4 hours pre-pandemic.
Meibomian Gland Dysfunction (MGD)
MGD is the leading cause of evaporative dry eye, the most common form.
Up to 86% of dry eye disease cases involve Meibomian Gland Dysfunction, making evaporative dry eye far more common than aqueous-deficient.
MGD prevalence is highest in Asian populations, affecting 59-69% of studied groups.
The estimated lifetime cost of managing moderate to severe dry eye disease ranges from $55,000 to $83,000 per patient.
Treatment Outcomes
Modern treatments show significant improvement in dry eye management.
Approximately 80% of patients treated with LipiFlow thermal pulsation show improvement in meibomian gland function at 12 months.
Up to 87% of dry eye patients treated with Intense Pulsed Light (IPL) therapy report improvement in symptoms.
Cyclosporine (Restasis) reduces signs and symptoms of dry eye in approximately 68% of patients by 6 months.
More Eye Health Data
Concerned About Your Eye Health?
Schedule a comprehensive eye exam with Dr. Bonakdar to assess your risk and discuss treatment options.